# Pilot: Insulin Sensitivity/Management in Hyperglycemic Patients in Perioperative Period ESRD/Non-ESRD

> **NCT03526536** · PHASE4 · TERMINATED · sponsor: **State University of New York - Downstate Medical Center** · enrollment: 40 (actual)

## Conditions studied

- End-Stage Renal Disease
- Diabetes Mellitus

## Interventions

- **DRUG:** IV Novolin R human insulin

## Key facts

- **NCT ID:** NCT03526536
- **Lead sponsor:** State University of New York - Downstate Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-01
- **Primary completion:** 2020-09-03
- **Final completion:** 2020-09-03
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** The study required more participants than anticipated for statistical significance.
- **Last updated:** 2020-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03526536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03526536, "Pilot: Insulin Sensitivity/Management in Hyperglycemic Patients in Perioperative Period ESRD/Non-ESRD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03526536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*